COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,051 Articles (22,627 medRxiv, 8,424 bioRxiv)

Most recent first Previous |  Page 445: Articles 4441-4450  | Next

Prevalence of IgG and IgM to SARS-CoV-2 and other human coronaviruses in The Democratic Republic of Congo, Sierra Leone and Uganda: A Longitudinal Study
Gallagher, K. E., Lawal, B. J., Kitonsa, J., Tindanbil, D., Kasonia, K., Drammeh, A., Lowe, B., Mukadi-Bamuleka, D., Patterson, C., Greenwood, B., Samai, M., Leigh, B., Tetteh, K. A., Ruzagira, E., Watson-Jones, D., Kavunga-Membo, H.
10.1101/2023.03.08.23286979 — Posted: 2023-03-10
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review
Drysdale, M., Gibbons, D. C., Singh, M., Rolland, C., Lavoie, L., Skingsley, A., Lloyd, E. J.
10.1101/2023.03.09.23287034 — Posted: 2023-03-10
Integrated analyses of single-cell RNA-seq public data reveal the gene regulatory network landscape of respiratory epithelial and peripheral immune cells in COVID-19 patients
Zhang, L., Nishi, H., Kinoshita, K.
10.1101/2023.03.09.23287043 — Posted: 2023-03-10
Medium-term scenarios of COVID-19 as a function of immune uncertainties and chronic disease
Saad-Roy, C. M., Morris, S. E., Baker, R. E., Farrar, J., Graham, A. L., Levin, S. A., Wagner, C. E., Metcalf, C. J. E., Grenfell, B. M.
10.1101/2023.03.08.23287004 — Posted: 2023-03-10
Clinical performance of a chemiluminescence SARS-CoV-2 antibody assay in a cohort of healthcare workers, blood donors and COVID-19 patients.
Rangel, G. A., Lopez, D., Chavarria, A., Mudarra, L., Britton, G. B., Villarreal, A. E.
10.1101/2023.03.09.23287052 — Posted: 2023-03-10
A single C-terminal residue controls SARS-CoV-2 spike trafficking and virion assembly
Dey, D., Qing, E., He, Y., Chen, Y., Jennings, B., Cohn, W., Singh, S., Gakhar, L., Schnicker, N. J., Pierce, B. G., Whitelegge, J. P., Doray, B., Orban, J. P., Gallagher, T., Hasan, S. S.
10.1101/2023.03.09.531992 — Posted: 2023-03-10
Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that bind a conserved membrane proximal epitope of the spike
De Cae, S., Van Molle, I., van Schie, L., Shoemaker, S. R., Deckers, J., Debeuf, N., Lameire, S., Nerinckx, W., Roose, K., Fijalkowska, D., Devos, S., Desmet, A.-S., Zavala Marchan, J. C., Venneman, T., Ghassabeh, G. H., Sedeyn, K., Ballegeer, M., Vanheerswynghels, M., De Wolf, C., Demol, H., Vanhaverbeke, P., Lonigro, C., Bockstal, V., Rinaldi, M., Abdelnabi, R., Neyts, J., Marqusee, S., Lambrecht, B. N., Callewaert, N., Remaut, H., Saelens, X., Schepens, B.
10.1101/2023.03.10.531533 — Posted: 2023-03-10
SARS-CoV-2 protein structure and sequence mutations: evolutionary analysis and effects on virus variants SARS-CoV-2 protein structure and sequence mutations:
Ugo, L., Barbara, P., Giuseppe, T., Guzzi, P. H., Pierangelo, V.
10.1101/2023.03.09.531961 — Posted: 2023-03-10
Impaired potency of neutralizing antibodies against cell-cell fusion mediated by SARS-CoV-2
Wang, Q., Yeh, A. Y., Guo, Y., Yu, J., Ho, D. D., Liu, L.
10.1101/2023.03.09.531948 — Posted: 2023-03-10
Molecular pathology of acute respiratory distress syndrome, mechanical ventilation and abnormal coagulation in severe COVID-19
Soule, A., Ma, W. R., Liu, K. Y., Allard, C., Qureshi, S., Tremblay, K., Emad, A., Rousseau, S.
10.1101/2023.03.09.23286797 — Posted: 2023-03-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).